{"resourceType":"ValueSet","id":"mcode-tnm-primary-tumor-category-vs","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include all codes defined in <code>http://cancerstaging.org</code></li></ul></div>"},"url":"http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-primary-tumor-category-vs","version":"1.0.2","name":"TNMPrimaryTumorCategoryVS","title":"TNM Primary Tumor Category Value Set","status":"active","date":"2020-12-13T18:35:37+00:00","publisher":"HL7 International Clinical Interoperability Council","contact":[{"name":"HL7 International Clinical Interoperability Council","telecom":[{"system":"url","value":"http://www.hl7.org/Special/committees/cic"},{"system":"email","value":"ciclist@lists.HL7.org"}]}],"description":"This value set is intended to contain allowable values for the T category, according to TNM staging rules. AJCC codes (preferably, version 8 for current cancers) SHOULD be used.\n\n* AJCC terminology: examples of T categories include 'cTX', used when the tumor primary tumor cannot be evaluated, 'pT0', denoting there is no evidence of a primary tumor, and 'pTis', referencing carcinoma in situ (with some cancer-specific exceptions). Other T categories refer to increasing size of the primary tumor. Please note allowable T categories may vary between clinicalÂ and pathologic classifications. The full set of allowable clinical and pathologic T categories, along with its current descriptions, can be accessed through the AJCC Staging Manual and any applicable updates and corrections, as well as the AJCC API.","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US","display":"United States of America"}]}],"compose":{"include":[{"system":"http://cancerstaging.org"}]}}